Stroke is the most common cause of epilepsy and ultimately leads to a decrease in the
quality of life of those affected. Ischemic and hemorrhagic strokes can both lead to …

The pathophysiology and treatment of post-stroke cognitive impairment (PSCI) are not clear.
Stroke triggers an inflammatory response, which might affect synapse function and cognitive …

The glial environment influences neurological disease progression, yet much of our
knowledge still relies on preclinical animal studies, especially regarding astrocyte …

Medicinal treatment against epilepsy is faced with intractable problems, especially
epileptogenesis that cannot be blocked by clinical antiepileptic drugs (AEDs) during the …

Background and Objective Stroke is one of the most frequent neurological syndromes in the
adult population and the cause of 10% of all diagnosed epilepsies. It is attributed to the …

Structural or post-traumatic epilepsy often develops after brain tissue damage caused by
traumatic brain injury, stroke, infectious diseases of the brain, etc. Most often, between the …

Background The multi-inflammatory index (MII) is a novel marker that indicates the
diagnosis, prognosis, and clinical severeness of inflammation-associated diseases. It is …

Introduction: In addition to clinical factors, blood-based biomarkers can provide useful
information on the risk of developing post-stroke epilepsy (PSE). Our aim was to identify …

Introduction The development of post-stroke epilepsy (PSE) is related to a worse clinical
outcome in stroke patients. Adding a biomarker to the clinical diagnostic process for the …

In 2019, over 130 people from several countries travelled to Gothenburg, Sweden, for the
Seizures and Stroke Congress, the first international conference devoted to post-stroke …